Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$1.06 - $1.67 $1.87 Million - $2.94 Million
-1,760,100 Reduced 72.36%
672,488 $780,000
Q4 2023

Jan 29, 2024

SELL
$1.26 - $1.79 $120,330 - $170,945
-95,500 Reduced 3.78%
2,432,588 $4.11 Million
Q3 2023

Oct 17, 2023

SELL
$1.61 - $2.54 $1.08 Million - $1.71 Million
-672,500 Reduced 21.01%
2,528,088 $4.58 Million
Q2 2023

Jul 12, 2023

SELL
$1.14 - $1.95 $507,370 - $867,870
-445,062 Reduced 12.21%
3,200,588 $5.95 Million
Q1 2023

Apr 28, 2023

SELL
$1.2 - $2.19 $522,962 - $954,406
-435,802 Reduced 10.68%
3,645,650 $4.85 Million
Q4 2022

Jan 31, 2023

BUY
$1.63 - $3.52 $2.93 Million - $6.32 Million
1,795,187 Added 78.52%
4,081,452 $6.9 Million
Q3 2022

Oct 11, 2022

SELL
$0.73 - $3.74 $125,049 - $640,662
-171,300 Reduced 6.97%
2,286,265 $7.13 Million
Q2 2022

Jul 18, 2022

BUY
$2.2 - $4.2 $1.75 Million - $3.34 Million
795,109 Added 47.83%
2,457,565 $5.85 Million
Q1 2022

Apr 22, 2022

BUY
$2.83 - $8.69 $4.48 Million - $13.8 Million
1,583,000 Added 1992.3%
1,662,456 $6.7 Million
Q4 2021

Jan 31, 2022

BUY
$8.31 - $14.92 $660,279 - $1.19 Million
79,456 New
79,456 $660,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.